https://www.selleckchem.com/pr....oducts/pyrrolidinedi
Immune-mediated diarrhea and colitis (IMDC) is currently diagnosed and monitored by evaluating clinical symptoms. Deep remission is determined by endoscopic and histologic evaluation of the disease process. However, repeating these invasive procedures frequently can become cumbersome. We sought to assess the role of fecal calprotectin (FC) concentration as a non-invasive biomarker of endoscopic or histologic remission. We performed a retrospective study of patients with IMDC who were tested for FC at
Aimer
Commentaire
Partagez
